Integrated Evidence Generation Planning: Why Medical Affairs is a Critical Partner.

Fujii R, Nouri M, Khan M, Fleisinger L, Pugh J, Male G, Panayi A

Open source

DOI
10.1007/s40290-026-00620-2
Published
2026 Sep
Container
Pharmaceutical medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40290-026-00620-2,
  title = {Integrated Evidence Generation Planning: Why Medical Affairs is a Critical Partner.},
  author = {Fujii R and Nouri M and Khan M and Fleisinger L and Pugh J and Male G and Panayi A},
  year = {2026},
  journal = {Pharmaceutical medicine},
  doi = {10.1007/s40290-026-00620-2},
  url = {https://doi.org/10.1007/s40290-026-00620-2}
}

RIS

TY  - JOUR
TI  - Integrated Evidence Generation Planning: Why Medical Affairs is a Critical Partner.
AU  - Fujii R
AU  - Nouri M
AU  - Khan M
AU  - Fleisinger L
AU  - Pugh J
AU  - Male G
AU  - Panayi A
PY  - 2026
JO  - Pharmaceutical medicine
DO  - 10.1007/s40290-026-00620-2
UR  - https://doi.org/10.1007/s40290-026-00620-2
ER  - 

APA

R, F., M, N., M, K., L, F., J, P., G, M., & A, P. (2026). Integrated Evidence Generation Planning: Why Medical Affairs is a Critical Partner.. Pharmaceutical medicine. https://doi.org/10.1007/s40290-026-00620-2

Source records